Cardiovascular complications of down syndrome: scoping review and expert consensus

…, A Constantine, P Clift, R Condliffe, S Moledina… - Circulation, 2023 - Am Heart Assoc
Cardiovascular disease is a leading cause of morbidity and mortality in individuals with Down
syndrome. Congenital heart disease is the most common cardiovascular condition in this …

Dynamic risk stratification of patient long-term outcome after pulmonary endarterectomy: results from the United Kingdom National Cohort

…, K Dimopoulos, SJ Wort, S Gaine, S Moledina… - Circulation, 2016 - Am Heart Assoc
… 590 dynes·s −1 ·cm −5 was correlated with poor longer-term outcome. Our results show a
slightly lower threshold with 416 dynes·s −1 ·cm −5 for all-cause mortality and 425 dynes·s −1 ·…

[HTML][HTML] Identification of rare sequence variation underlying heritable pulmonary arterial hypertension

…, G Kovacs, RV MacKenzie Ross, S Moledina… - Nature …, 2018 - nature.com
… We applied a one-tailed Fisher’s exact test with post hoc Bonferroni correction to calculate
… We applied a one-tailed (greater) Fisher’s exact test with Bonferroni post hoc correction for …

Childhood idiopathic pulmonary arterial hypertension: a national cohort study

S Moledina, AA Hislop, H Foster, I Schulze-Neick… - Heart, 2010 - heart.bmj.com
Objective To clarify the clinical characteristics and epidemiology of idiopathic pulmonary
arterial hypertension (IPAH) in childhood, a rare condition with a bad prognosis, poorly …

Risk factors for recurrence of primary sclerosing cholangitis of liver allograft

…, S Moledina, B Gunson, S Hubscher, D Mirza, S Olliff… - The Lancet, 2002 - thelancet.com
Primary sclerosing cholangitis (PSC) is a disease of unknown cause that effects the biliary
tree and is closely associated with inflammatory bowel disease. We did a retrospective …

[HTML][HTML] Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis

…, K Marsolo, LJ Martin, S Moledina… - The lancet respiratory …, 2019 - thelancet.com
Background Rare genetic variants cause pulmonary arterial hypertension, but the contribution
of common genetic variation to disease risk and natural history is poorly characterised. …

Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension

…, R Machado, R MacKenzie Ross, S Moledina… - Circulation, 2017 - Am Heart Assoc
Background: Pulmonary arterial hypertension (PAH) is a rare disease with an emerging
genetic basis. Heterozygous mutations in the gene encoding the bone morphogenetic protein …

Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI)

…, A Lungu, JA Mazurek, S Moledina… - Pulmonary …, 2019 - journals.sagepub.com
… Other echocardiographic measures include the myocardial performance (Tei) index 70
and S’ obtained from tissue Doppler imaging of the tricuspid annulus. Markers of adverse …

Prognostic significance of cardiac magnetic resonance imaging in children with pulmonary hypertension

S Moledina, B Pandya, M Bartsota… - Circulation …, 2013 - Am Heart Assoc
… Volumetric data were obtained using retrospectively gated cine imaging (n=37) or real-time
imaging (n=63), depending on the patient’s ability to hold his or her breath. During a median …

Executive summary. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular …

…, H Latus, I Michel-Behnke, O Miera, S Moledina… - Heart, 2016 - heart.bmj.com
… If you wish to reuse any or all of this article please use the link below which will take you to
the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and …